ページの先頭です

健康コラム健康コラム

医療スタッフのための刊行物(書籍及び論文等)のご案内です。


邦書集

 
   New 坂田芳人、杉本達哉:「Overview 心原性ショックで来院する心血管エマージェンシー」 pp1219‐1223 、特集「すぐそこにある心血管エマージェンシー」 内科 Vol. 120 No.6, 2017年
 
   富野康日己:「メディカルスタッフのための腎臓病学(改訂2版)
    中外医学社、2017年4月5日(初版2013年3月5日)
 
   富野康日己(監修):「内科外来診断navi
    中外医学社、2017年4月5日
 
   関 卓人、富野康日己:
42. 透析用潅流用剤」pp536‐538、「ポケット版 治療薬UP-TO-DATE(2017年版)」(監修 矢崎義雄)、メディカルレビュー社
 
   (Round Table Discussion)富野康日己(司会)、秋葉隆、木村健二郎、細谷龍男、柏原直樹:
    「腎臓病学の課題と未来―Nephrology Frontier誌の足跡と貢献―」pp6-15、
    特集「腎臓病学の課題と未来―Nephrology Frontier誌の足跡と貢献―」Nephrology Frontier Vol.15 No.4, 2016年12月
 
   (座談会)富野康日己(司会)、川村哲也、安田隆、鈴木祐介、城謙輔:
    「CKD診療ガイドラインのIgA腎症診療へのインパクト」pp6-15、
    「Nephrology Frontier  -特集『慢性腎不全(CKD)としてのIgA腎症』-」Vol.15 No.3, 2016年9月
 
   「久田温子:常染色体優性遺伝例。難病 遺伝性血管性浮腫HAE.大澤 勲編。」
    医薬ジャーナル社、2016
   栄養士と看護師、薬剤師のための生活習慣病ケースファイル
    中外医学社、2016年8月5日 : 富野康日己

   腎臓病の人のためのひと目でよくわかる食品成分表」(Gakken)
     監修:富野康日己、松和会グループ栄養士部会協力


   糖尿病性腎症をどう治療する?
     わが国と世界における糖尿病性腎症の現状は?

      jmed 42,日本医事新報社, 2016 : 富野康日己

   内科診断学 第3版
      医学書院、2016 : 富野康日己他

   Annual Review 2016, 腎臓
      編集 富野康日己他、中外医学社

    「酸化ストレス調整効果 アスタキサンチン
     特集―慢性腎臓病レシピ食の力への期待
     「腎と透析」Vol.79 No.5 743-746、2015年11月 :富野康日己

   自己免疫性尿細管間質性疾患
     別冊 日本臨床 免疫症候群(第2版) 2015 34:426-429 :富野康日己

   不明熱・消化管外腫瘤で発症した炎症性悪性線維性組織球腫の1血液透析症例
     
透析会誌 2015 48:605-610
     神田怜生、佐藤大輔、相澤昌史、平井 周、富野康日己、船曳和彦

   腎透析予防と治療のための食事
     アンチエイジング医学の基礎と臨床 第3版。
     MEDICAL VIEW。231-232 :富野康日己

   症例でわかる実臨床で注意すべき副作用とモニタリング
     4.腎疾患。調剤と情報。2015,21:38-43 :富野康日己

   腎機能低下患者への薬の使い方
     皮膚病診療 2015、37:634-640 :富野康日己

   NEWエッセンシャル腎臓内科学 第2版
     富野康日己:医歯薬出版、東京

   検査で発見・進行させない人工透析の予備軍「慢性腎臓病(CKD)」
     富野康日己、ヘルスアンドライフ第366号:4-9 法研

   慢性腎臓病における左室肥大および腎不全の推移に関連する予測因子の検討
     富野康日己、井尾浩章【監修】:中外製薬、東京

   南山堂医学大辞典 第20版
     富野康日己(共著):南山堂、東京

 

洋書集

《2017年》

  New Atikemu Kelimu, Yusuke Suzuki, Mareki Otsuji, Satoshi Horikoshi, Yasuhiko Tomio;
“Influence of Estrogen on the Progression of Kidney Injury in Murine IgA Nephropathy”
June 2017, Juntendo Medical Journal 2018, 63(3), 178-185

   Bellur SS, Lepeytre F, Vorobyeva O, Troyanov S, Cook HT, Roberts IS; International IgA Nephropathy Working Group:
 “Evidence from the Oxford Classification cohort supports the clinical value of subclassification of focal segmental glomerulosclerosis in IgA nephropathy”
  Kidney Int. January 2017; 91(1):235-243.  DOI: 10.1016/j.kint.2016.09.029. Epub 2016 Dec 1. PMID: 27914703

   Kanda R, Io H, Nakata Y, Sasaki Y, Matsumoto M, Wakabayashi K, Tomino Y, Suzuki Y.:
 “Evaluation of Long-Term Combination Therapy With Peritoneal Dialysis and Hemodialysis”
   Ther Apher Dial.  April 2017; 21(2): 180-184.  DOI: 10.1111/1744-9987.12517

   Wakabayashi K, Io H, Nakata J, Nakamoto H, Sato M, Sasaki Y, Shimizu Y, Horikoshi S, Tomino Y, Suzuki Y:
 “Effects of Cardiac Function with Postoperative Arteriovenous Fistula Blood Flow in Patients with Hemodialysis”
  Blood Purif. February 2017  25; 44(1):24-29.  DOI: 10.1159/000458146.

   Sannohe T, Ohnuma T, Takeuchi M, Tani E, Miki Y, Takeda M, Katsuta N,Takebayashi Y, Nakamura T, Nishimon S, Kimoto A, Higashiyama R, Shibata N,Gohda T, Suzuki Y, Yamagishi SI, Tomino Y, Arai H:
 “High doses of antipsychotic polypharmacy are related to an increase in serum levels of pentosidine in patients with schizophrenia”
  Prog Neuropsychopharmacol Biol Psychiatry.
  March 7, 2017; 76:42-48.  DOI: 10.1016/j.pnpbp.2017.02.019.

   Murakoshi M, Gohda T, Sonoda Y, Suzumi H, Tomino Y, Horikoshi S, Suzuki Y:
 “Effect of tonsillectomy with steroid pulse therapy on circulating tumor necrosis factor receptors 1 and 2 in IgA nephropathy”
  Clin Exp Nephrol. April 7, 2017  DOI: 10.1007/s10157-017-1408-7.

   Shohei Nishimon, Tohru Ohnuma, Yuto Takebayashi, Narimasa Katsuta, Mayu Takeda, Toru Nakamura, Takahiro Sannohe, Ryoko Higashiyama, Ayako Kimoto, Nobuto Shibata, Tomohito Gohda, Yusuke Suzuki, Sho-ichi Yamagishi, Yasuhiko Tomino, Heii Arai:
 “High serum soluble tumor necrosis factor receptor 1 predicts poor treatment response in acute-stage schizophrenia.”
  Progress in Neuro-Psychopharmacology & Biological Psychiatry
  Volume76,2 June 2017,Pages 145-154. March 2017
  DOI: http://dx.doi.org/10.1016/j.pnpbp.2017.03.006

   Takahiro Sannohe, Tohru Ohnuma, Masayoshi Takeuchi, Eriko Tani, Yasue Miki, Mayu Takeda, Narimasa Katsuta, Yuto Takebayashi, Toru Nakamura, ShoheiNishimon, Ayako Kimoto, Ryoko Higashiyama, Nobuto Shibata, Tomohito Gohda, Yusuke Suzuki, Sho-ichi Yamagishi, Yasuhiko Tomino, Heii Arai:
 “High Doses of antipsychotic polypharmacy are related to an increase in serum levels of pentosidine in patients with schizophrenia”
  Progress in Neuro-Psychopharmacology & Biological Psychiatry
  Volume76,2 June 2017,Pages 42-48.
  DOI: http://dx.doi.org/10.1016/j.pnpbp.2017.02.019

   Yasuhiko Tomino:
 “Case Studies on Kidney Diseases -20 Typical Cases-(2nd revised edition)”, Karger, 2017

 

《2016年》

    Barbour SJ, Espino-Hernandez G, Reich HN, Coppo R, Roberts IS, Feehally J, Heizenberg AM, Cattran DC; Oxford Derivation, North American Validation and VALIGA Consortia; Oxford Derivation North American Validation and VALIGA Consortia. :
 “The MEST score provides earlier risk prediction in IgA nephropathy”
  Kidney Int. January 2016; 89(1):167-75.  DOI: 10.1038/ki.2015.322
  *Collaboratorsとして参加

   Watanabe Y, Akizawa T, Saito A, Gejyo F, Suzuki M, Nishizawa Y, Tomino Y, Tsubakihara Y, Akiba T, Hirakata H, Kawanishi H, Bessho M, Udagawa Y, Aoki K, Uemura Y, Ohashi Y; Co-JET Study Group:
 “Effect of Predialysis recombinant Human Erythropoietin on Early Survival After Hemodialysis Initiation in Patients With Chronic Kidney Disease: Co-Jet Study.”
  Ther Apher Dial. December 2016; 20(6):598-607.  DOI: 10.1111/1744-9987.12425. Epub 2016 December 7. PMID: 27928910

   Yoshio Shimizu, Takashi Kobayashi, Hitoshi Suzuki, Yusuke Suzuki, Satoshi Horikoshi and Yasuhiko Tomino
 “Chronological Change of the Serum IgA/C3 Ratio Indicates the Efficacy of Tonsillectomy for IgA Nephropathy”
  JBR Journal of Clinical Diagnosis and Research 2016, Volume 4 Issue 1, DOI: 10.4172/2376-03111,1000132

  Mayumi Idei, Yoko Tabe, Chieko Hamada, Kazunori Miyake, Hiroyuki Takemura,Hiroaki Ito, Mitsuru Wakita, Takashi Horii, Yasuhiko Tomino, Akimichi Ohsaka,Takashi Miida
   “Pancreatic lipase activity in overnight effluent predicts high transport status in peritoneal dialysis patients”
     Clinica Chimica Acta 462 (2016)65-70. DOI: 10.1016/j.cca.2016.08.009
 
   Yuzo Wantanabe, Tadao Akizawa, Akira Saito, Fumitake Gejyo, Masashi Suzuki,Yoshiki Nishizawa, Yasuhiko Tomino, Yoshiharu Tsubakihara, Takashi Akiba, Hideki Hirakata, Hideki Kawanishi, Masami Bessho, Yukio Udagawa, Kotonari Aoki, Yukari Uemura, Yasuo Ohashi, and the Co-JET Study Group: “Effect of Predialysis Recombinant Human Erythropoietin on Early Survival After hemodialysis Initiation in Patients With Chronic Kidney Disease: Co-JET Study”, Therapeutic Apheresis and Dialysis 2016, 1-10, DOI: 10.111/1744-9987.12425
 
   Kanae Yamamoto-Nonaka, Masato Koike, Katsuhiko Asanuma, Miyuki Takagi, Juan Alejandro Oliva Trejo, Takuto Seki, Teruo Hidaka, Koichiro Ichimura, Tatsuo Sakai, Norihiro Tada, Takashi Ueno, Yasuo Uchiyama, and Yasuhiko Tomino: “Cathepsin D in Podocytes Is Important in the Pathogenesis of Proteinuria and CKD”. J am Soc Nephrol 27: 2685-2700, 2016
 
   Takao Saito, Masayuki Iwano, Koichi Matsumoto, Tetsuya Mitarai, Hitoshi Yokoyama, Noriaki Yorioka, Shinichi Nishi, Ashio Yoshimura, Hiroshi Sato, Satoru Ogahara, Yoshie Sasatomi, Yasufumi Kataoka, Shiro Ueda Akio Koyama,Shoichi Maruyama, Masaomi Nangaku, Enyu Imai, Seiichi Matsuo, Yasuhiko Tomino, “The Refractory Nephrotic Syndrome Study Group: Mizoribine therapy combined with steroids and mizoribine blood concentration monitoring for idiopathic membranous nephropathy with steroid-resistant nephrotic syndrome”. Clin Exp Nephrol, October 25 2016, DOI 10.1007/s10157-016-1340-2, 2016
 
   Shuntaro Maruyama, Tomohito Gohda, Yusuke Suzuki, Hitoshi Suzuki, Yuji Sonoda, Saki Ichikawa, Zi Li, Maki Murakoshi, Satoshi Horikoshi, Yasuhiko Tomino: “Beneficial Effects of Tonsillectomy plus Steroid Pulse Therapy on Inflammatory and Tubular Markers in Patients with IgA Nephropathy”. Kidney Research and Clinical Practice (2016), DOI: 10.1016/j.krcp.2016.09.002.
 
   Yasuhiko Tomino: “Diagnosis and treatment of patients with IgA nephropathy, one of major causes of chronic kidney disease (CKD), in Japan”. Kidney Research and Clinical Practice 2016 (DOI: 10.1016/j.krcp.2016.09.001)
 
  Yasuhiko Tomino( Editor). “Pathogenesis and Treatment in IgA Nephropathy”, Springer, 2016.
 
  Takahashi T, Baba K, Ogawa T, Okamoto  Y, Tajima T, Agawa T, Kondo T, Yanai K: Age-specific
    “distribution of estimated glomerular filtration rate using Japanese health checkup data”. HEP 43: 518-523, 2016
 
  Tomino Y, et al. “IgA nephropathy”. Nature Review 2016; 2: 1-20.
 

《2015年》

 
  Io H, Tomino Y, et al.: “Impact of anaemia treatment for left ventricular remodeliing prior to initiation of dialysis in chronic kidney disease patients: Efficacy and stability of long acting erythropoietin stimulating agents”. Nephrolo 20, Suppl. 4(2015) 7-13
 
  Beom Seok Kim, Yasuhiko Tomino, “et al. Is the new GFR equation using inulin clearance a more accurate method for Asian patients?” Clin Nephrol 2015
 
  Yasuhiko Tomino: “New Biomarkers for diagnosis in patients with chronic kidney disease (CKD)”. Special Reviews: Farewell Lecture of Retiring Professors. Juntendo Medical Journal. 2015, 61:257-263
 
  Yasuhiko Tomino : “Clinicopathological Findings of IgA nephropathy”. Juntendo Medical Journal 2015,61:2-4
 
  Yasuhiko Tomino, Tomohito Gohda:  “The Prevalence and Management of Diabetic Nephropathy in Asia, Diabetic Nephropathy”. Kidney Dis 2015;1:52-60 (DOI: 10.1159/000381757)
 

《2014年》

  Nagamachi s, Ohsawa I, Suzuki H, Sato N, Inoshita H, Hisada A, Honda D, Shimamoto M, Shimizu Y, Horikoshi S, Tomino Y:
“Properdin has an ascendancy over factor H regulation in complement-mediated renal tubular damage”. BMC Nephrol, 2014; 15:82.

  Nakata J, Suzuki Y, Suzuki H, satake K, Horikoshi S, Novak J, Tomino Y:
“The kinetics of glomerular deposion of nephritogenic IgA”. PLoS One, 2014; 9: e89707

   Suzuki Y, Matsuzaki K, Suzuki H, Sakamoto N, Joh K, Kawamura T, Tomino Y, Matsuo s:
“Proposal of remission criteria for IgA nephropathy”. Clin Exp nephrol, 2014;18: 481-486

   Suzuki H, Raska M, Yamada K, Moldoveanu Z, Julian BA, Wyatt RJ, Tomino Y, Gharavi AG, Novak J:
“Cytokines alter IgA1 O-glycosylation by dysregulating C1GalT1 and St6GalNAc-Ⅱenzymes”. J Biol Chem, 2014; 289: 5330-5339

    Suzuki Y, Matsuzaki K, Suzuki H, Okazaki K, Yanagawa H, Ieiri N, Sato M, Sato T, Taguma Y, Matstuoka J, Horikoshi S, Novak J, Hotta O, Tomino Y:
“Serum levels of galactose-deficient immunoglobulin (Ig) A1 and related immune complex are associated with disease activity of IgA nephropathy”. Clin Exp Nephrol, 2014; 18: 770-777.

    Akizawa T, Saito A, Gejyo F, Suzuki M, Nishizawa Y, Tomino Y, Tsubakihara Y, Akiba T. Hirakata H, Watanabe Y, Kawanishi H, Bessho M, Udagawa Y, Aoki K, Uemura Y, Ohashi Y:
“Co-JET Study Group: Impacts of recombinant human erythropoietin treatment during predialysis periods on the progression of chronic kidney disease in a large-scale cohort study (Co-JET study)”. Ther Apher Dial, 2014; 18: 140-148.

   Satake K, Shimizu Y, Sasaki Y, Yanagawa H, Suzuki H, Suzuki Y, Horikoshi S, Honda S, Shibuya K, Shibuya A, Tomino Y:
“Serum under-O-glycosylated IgA1 lever is not correlated with glomerular IgA deposition based upon heterogeneity in the composition of immune complexes in IgA nephropathy”. BMC Nephrol, 2014; 15:89.

   Shimamoto M, Ohsawa I, Suzuki H, Hisada A, Nagamachi S, Honda D, Inoshita H, Shimizu Y, Horikoshi s, Tomino Y:
“Impact of body mass index on progression of IgA nephropathy amang Japanese patients”. J Clin Lab Anal, Ephb 2014 Aug 17

 

  Get ADOBE READER PDFをご覧になるには,「Adobe Reader(無料)」が必要な場合があります。